IP Library Granted Patent US 10,751,215
Granted Patent B2
US 10,751,215 · App. 16/789,658 · Granted Aug 25, 2020

Systems and methods for treating eye diseases

Inventors: Michael Calhoun (Lighthouse Point, FL); Jeff Franco (Plano, TX); Robert M. Vidlund (Forest Lake, MN)
Assignee: J.D. Franco & Co., LLC
A61F9/007A61B3/16A61B5/026A61B5/6866A61B17/12109A61B17/12136A61B17/221A61B17/320725A61B17/320758A61F2/856A61F2/966A61F9/00781A61M1/10A61M1/3621A61M1/3627A61M25/01A61M25/1002A61M25/104A61M27/00A61B17/12009A61B2017/00986A61B2017/22061A61B2017/22079A61B2090/064A61F2/82A61F2002/821A61M25/0068A61M2025/0186A61M2025/0681A61M2025/09008A61M2025/1052A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,751,215
App. No.
16/789,658
Granted
Aug 25, 2020
Kind
B2
Abstract

A method may include accessing a terminal branch of an ophthalmic artery through a face of a subject. Additionally, the method may include positioning a device within the ophthalmic artery of the subject and treating at least one of a blockage, a stenosis, a lesion, plaque or other physiology in at least one of the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

Claims (30)

1. A method for treating glaucoma or age-related macular degeneration (AMD), comprising:

accessing an ophthalmic artery through an access vasculature site of a subject via a first device;

positioning the first device or a second device within the ophthalmic artery of the subject; and

treating glaucoma or AMD by increasing a size of a lumen of the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

2. The method of claim 1 , wherein the accessing the ophthalmic artery includes accessing the ophthalmic artery through a skin of the head of the subject via a supraorbital artery or a supratrochlear artery of the subject via the first device.

3. The method of claim 1 , wherein the increasing the size of the lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes removing material.

4. The method of claim 1 , wherein the increasing the size of the lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes using a balloon in a balloon dilation procedure.

5. The method of claim 1 , further including measuring a blood flow rate in the ophthalmic artery, including measuring at least one of a linear blood flow rate or a volumetric blood flow rate.

6. The method of claim 1 , further including stopping antegrade blood flow in the ophthalmic artery.

7. A method for treating glaucoma or age-related macular degeneration (AMD), comprising:

positioning a first device in an access vasculature site of a subject;

advancing a second device through a lumen of the first device, the second device having a distal portion angled with respect to a longitudinal axis of a portion of the second device proximal of the distal portion;

cannulating an ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery via the distal portion of the second device; and

treating a blockage, a stenosis, a lesion, plaque, or other physiology in the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery, wherein the treating includes increasing a blood flow rate in the ophthalmic artery to treat glaucoma or AMD.

8. The method of claim 7 , wherein the treating the blockage, the stenosis, the lesion, the plaque, or the other physiology further includes increasing a size of a lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery.

9. The method of claim 8 , wherein the increasing the size of the lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes removing material.

10. The method of claim 9 , wherein the increasing the size of the lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes using a balloon in a balloon dilatation procedure.

11. The method of claim 9 , wherein the increasing the size of the lumen of the ophthalmic artery or the junction between the internal carotid artery and the ophthalmic artery includes using an atherectomy device in an atherectomy procedure.

12. The method of claim 7 , further including inducing retrograde blood flow in the ophthalmic artery.

13. The method of claim 7 , further including measuring a blood flow rate in the ophthalmic artery.

14. The method of claim 13 , wherein the measuring the blood flow rate in the ophthalmic artery includes measuring a linear blood flow rate.

15. The method of claim 13 , wherein the measuring the blood flow rate in the ophthalmic artery includes measuring a volumetric blood flow rate.

16. A method for treating glaucoma or age-related macular degeneration (AMD), comprising:

locating a site in an arterial blood supply to an eye that compromises blood flow and contributes to glaucoma or AMD;

delivering a first device intravascularly to the site, the first device including a nonlinear distal end portion;

cannulating the site via the nonlinear distal end portion of the first device; and

treating the site with the first device or a second device, wherein the site is located in the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.

17. The method of claim 16 , further including stopping antegrade blood flow in the ophthalmic artery or inducing retrograde blood flow in the ophthalmic artery.

18. The method of claim 17 , further including measuring a blood flow rate in the ophthalmic artery, including measuring at least one of a linear blood flow rate or a volumetric blood flow rate.

19. The method of claim 16 , wherein treating the site includes using a balloon in a balloon dilation procedure and/or using an atherectomy device in an atherectomy procedure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: OCUDYNE, INC.
To: J.D. FRANCO & CO., LLC
Reel/Frame 052668/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2020
From: CALHOUN, MICHAEL; FRANCO, JEFF; VIDLUND, ROBERT M.
To: OCUDYNE, INC.
Reel/Frame 052174/0184 →
Continuity (15)
Continuation 16583508 · Sep 26, 2019
Continuation 16415506 · May 17, 2019
Continuation 16228316 · Dec 20, 2018
Continuation In Part 15971809 · May 4, 2018
Continuation 15681075 · Aug 18, 2017
Continuation PCTUS2017021673 · Mar 9, 2017
Continuation In Part PCTUS2017051551 · Sep 14, 2017
Continuation In Part 15609547 · May 31, 2017
Continuation 14385496
Provisional Application 62305991 · Mar 9, 2016
Provisional Application 62396091 · Sep 16, 2016
Provisional Application 62314340 · Mar 28, 2016
Provisional Application 62395294 · Sep 15, 2016
Provisional Application 61679351 · Aug 3, 2012
Related Publication 20200179162A1 · Jun 11, 2020
Cited By (1)
US 12,318,327